PRE Q1 2024 Earnings — Prenetics Global Limited Revenue & Financial Results | Market Cap Arena

PREPrenetics Global Limited

$287M

Q1 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$6M+30.2% YoY

Gross Profit

$4M59.0% margin

Operating Income

-$9M-142.8% margin

Net Income

-$9M-133.6% margin

EPS (Diluted)

$-0.70

QoQ Revenue Growth

+21.5%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$244M

Total Liabilities

$41M

Stockholders' Equity

$199M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+30.2%
Gross Profit	$4M	$1M	+159.7%
Operating Income	-$9M	-$15M	+38.5%
Net Income	-$9M	-$10M	+17.6%